Clinical Trial Update: Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selective internal radiation therapy with Xelox, bevacizumab, and atezolizumab in patients with liver-dominant metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Metastatic Colorectal Cancer, pMMR | Phase 2 | Status: UNKNOWN